Medtech grants in Belgium

Funds clinical trials advancing new or improved antimalarial drug combinations toward registration and access in sub-Saharan Africa.

Funds 4 regional research networks in sub-Saharan Africa to run multi-country clinical trials and rapid outbreak-response research.

Funds clinical trials of TB vaccine candidates and licensed vaccines targeting adolescents, adults and vulnerable groups in sub-Saharan Africa.

Funds late-stage clinical trials on treating co-infections and co-morbidities in people living with HIV, not HIV itself, across sub-Saharan Africa.

Funds host institutions in sub-Saharan Africa to run Master's fellowships and short courses in epidemiology, biostatistics and infectious-disease modelling, worth up to EUR 90,000 per fellow.

Funds a platform and roadmap that connects biotech companies, health-data holders and AI Factories to accelerate AI-driven biotech innovation.

Closed

Funds research standardising how scientists detect and measure micro- and nanoplastics in the human body, and building evidence on their long-term health effects.

Closed

Pays for secure federated storage and processing capacity for Europe's shared genomic-data infrastructure, the 1+ Million Genomes initiative.

Closed

Funds tools and APIs that curate and share genomic data for research, healthcare and public-health uses across Europe's Health Data Space.

Funds R&D on rapid tests that detect chemical and biological agents, including biotoxins.

Funds R&D on vaccines and drugs that protect against chemical, biological, radiological and nuclear threats.

Funds R&D on reusable respiratory protective equipment and protection suits against chemical, biological, radiological and nuclear threats.

Closed

Funds research that measures wasteful or low-value healthcare practices and pilots ways to cut them, freeing up resources for care that actually helps patients.

Closed

Funds medical, technological and care research that prevents, reverses or reduces the severity of intellectual disability and supports the families who care for those affected.

Closed

Funds clinical trials of new drug-based therapies, paired with a complementary approach like neurostimulation or digital monitoring, for conditions such as depression, schizophrenia, PTSD and autism spectrum disorder.

Closed

Funds clinical trials that validate affordable, minimally-invasive surgery-centred treatments for cancer patients with locally advanced or metastatic disease.

Funds one project to standardise beta-cell manufacturing, immune-tolerance strategies and clinical criteria that speed up cell therapy for type 1 diabetes.

Closed

Funds multi-country clinical studies that generate the safety and performance data device makers need for CE marking of orphan or breakthrough medical devices.

Closed

Funds development of lab-grown human tissue models, organ-on-chip systems and AI-driven simulations that can replace animal testing in drug and medical device development.

Funds late-stage development of new diagnostic tests for vector-borne diseases such as those spread by mosquitoes and ticks.

Closed

Pays three European projects EUR 7.5 million each to develop advanced-materials sensors, from multifunctional surfaces to miniaturised wearable devices, with a guaranteed award in each of two research areas.

Closed

Funds research linking diet and nutrients to mental health, aiming at evidence and guidance for policymakers and health professionals.

Closed

Funds industry-academia consortia that refine and scale up the manufacturing process for one class of cell or gene therapy, from quality control through to deployment.

Funds one project to map, replace, reduce and safely dispose of PFAS chemicals used in medicines, vaccines, devices and diagnostics.